GlassScriptPhysician profile
Benton A Emblom
NPI 1588873350
$2,986,387.16
in general payments reported to CMS, 2019-2025
12 companies · $857K in 2025
The $857K reported for 2025 was more than what 99% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $59K · 2020: $149K · 2021: $248K · 2022: $284K · 2023: $627K · 2024: $761K · 2025: $857K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $2.2M · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $34K · Consulting Fee: $22K · Food and Beverage: $2,612 · Travel and Lodging: $1,634.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $2,185,400.19 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $33,952.03 |
| Consulting Fee | $21,500.00 |
| Food and Beverage | $2,612.44 |
| Travel and Lodging | $1,633.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $2,982,960.69 | 2019-2025 | Arthrex, Shoulder Implants Rotator Cuff Fibertak, Shoulder Implants Fibertak Knotless |
| Prime Surgical, LLC | $999.22 | 2019-2025 | |
| Zimmer Biomet Holdings, INC. | $903.67 | 2019-2024 | Gel-One Cross-Linked Hyaluronate |
| Stryker Corporation | $771.81 | 2019-2025 | Inspace, Mako, Air |
| Pacira Therapeutics, INC. | $258.32 | 2019 | |
| Orthalign INC | $184.64 | 2025 | Orthalign Plus |
| Djo, LLC | $149.47 | 2019 | |
| Depuy Synthes Sales INC. | $80.54 | 2025 | Na |
| Conmed Corporation | $22.75 | 2025 | Visiclear, System 2450 |
| Molnlycke Health Care US, LLC | $22.70 | 2025 | Mepilex Border Post-Op Ag |
| Convatec INC. | $18.67 | 2025 | |
| Daiichi Sankyo INC. | $14.68 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benton Emblom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.